indole-based endothelin antagonists (Pfizer)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameindole-based endothelin antagonists (Pfizer)
Drug Alias NamePD-156707 analogs (Pfizer)L-749329 analogs (Pfizer)endothelin ET-A antagonists (Pfizer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type A antagonists
TargetsEndothelin receptor type A
Therapy Area/IndicationsIschemiaHypertensionCoronary Restenosis +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsIschemiaHypertensionCoronary Restenosis +[7] 

Other Information

ATC CodeN/A
Related LinksN/A